Chronic kidney disease could cost Australia $12bn

CHRONIC kidney disease could cost Australia $12 billion in five years, research claims.

Research published today in the Medical Journal of Australia found the focus must be placed on preventing kidney disease to stop a growing financial burden.

Researchers Dr Titi Chen and Professor David Harris found Australia's aging population; the growing prevalence of diabetes; hypertension and obesity had led to more than 20,000 people having end-stage kidney disease and 1.7 million adults having the disease's indicators.

Due to this, renal replacement therapy accounted for about 3% of the nation's total health expenditure.

"It is estimated that the cumulative cost of providing treatment to new and existing patients with ESKD in Australia from 2009 to 2020 will reach $12 billion," the researchers wrote.

"This places a great burden on society.

They found chronic kidney disease's close association with cardiovascular disease also had an impact on health spending.

"CKD is a silent disease that can remain asymptomatic until it reaches an advanced stage, therefore most people with CKD are unaware they have the condition."